发明授权
US09545413B2 Methods of forming ciclopirox or derivatives thereof in a subject by administration of prodrug
有权
通过给药前药在受试者中形成环吡酮或其衍生物的方法
- 专利标题: Methods of forming ciclopirox or derivatives thereof in a subject by administration of prodrug
- 专利标题(中): 通过给药前药在受试者中形成环吡酮或其衍生物的方法
-
申请号: US14966323申请日: 2015-12-11
-
公开(公告)号: US09545413B2公开(公告)日: 2017-01-17
- 发明人: Mehmet Tanol , Scott Weir
- 申请人: The University of Kansas
- 申请人地址: US KS Lawrence
- 专利权人: UNIVERSITY OF KANSAS
- 当前专利权人: UNIVERSITY OF KANSAS
- 当前专利权人地址: US KS Lawrence
- 代理机构: Stinson Leonard Street LLP
- 主分类号: A01N57/00
- IPC分类号: A01N57/00 ; A61K31/675 ; C07F9/58 ; C07F9/59 ; C07F9/09 ; C07F9/11
摘要:
A method of forming a compound in a subject can include: providing a composition having a prodrug compound represented by a structure of Formula 1 or stereoisomer thereof or pharmaceutically acceptable salt thereof; and administering the composition to a subject such that the prodrug compound has a phosphoryloxyalkyl prodrug moiety removed therefrom to form the compound in the subject and to form the separate phosphoryloxyalkyl compound. The prodrug can be included in a pharmaceutical composition for use in treatment of fungus, various cancers (e.g., bladder, breast, etc.), dermatitis, superficial mycoses; inflammation, tinea pedis, tinea cruris, and tinea corporis, Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis, candidiasis (moniliasis), Candida albicans, tinea (pityriasis) vesicolor, Malassezia furfur, acute myeloid leukemia, acute lymphoid leukemia, chronic myelogenous leukemia, lymphoma or multiple myeloma.
公开/授权文献
信息查询